is a glp 1 insulin Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research – Caltag Medsystems Glucagon-like peptide-1 - Wikipedia

Cinnamon Use in Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis

On 1 April 2026, the FDA approved Foundayo (orforglipron) for adults with obesity or overweight with weight-related medical conditions, making it the first small-molecule oral GLP-1 receptor agonist to receive regulatory clearance anywhere in the world

Weber V, Fehmann V, Goke R, Goke B

Also, talk about whether a lower dose or a slower weight loss journey would be safer for avoiding side effects

Docusate sodium (Colace)

It offers: Far more durable results than short-term medical therapy Better long-term value than years of expensive brand-name injections Powerful metabolic improvement A path that does not depend on indefinite prescriptions For the right candidate, gastric sleeve is not just an alternative to GLP-1 drugs